Bufexamac
Bufexamac is a small molecule COX inhibitor that promotes IFN-α release, exhibiting anti-inflammatory, analgesic, and antipyretic properties. It is used in research to study inflammatory pathways and has been applied in both in vitro assays and in vivo animal models of inflammation and pain.
Product Specifications
CAS Number
2438-72-4
Product Name Alternative
Bufexamac, Bufexamic acid, IFN-α, Inhibitor, HDAC, Histone deacetylases, inhibit
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation, Metabolism Research, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
95.99% (May vary between batches)
Solubility
Ethanol:3 mg/mL (13.44 mM) ; DMSO:70 mg/mL (313.52 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
C (C (NO) =O) C1=CC=C (OCCCC) C=C1
Molecular Formula
C12H17NO3
Molecular Weight
223.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
REXO2 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Rabbit Anti-Bovine Insulin Like Growth Factor Binding Protein 3 (IGFBP3) Polyclonal Antibody
